Strategic business and legal adviser to co-founders of restaurant group focused on providing high quality & affordable food for delivery and pickup.

Attorney overseeing corporate transactional practice for firm.

Business and legal adviser to founders focused on a human-centered approach to bring out the highest potential in for clients through collaborative, innovative consulting practices and technology.

CEO for Expa Medical Devices, Inc., a medical device company developing a novel breast implant that will eliminate one of the two surgeries for breast cancer patients. Our expandable implants will also have applicability in the traditional augmentation markets.

Adviser to Myoscience CEO from January 1 through April 9, 2019 for $220 million acquisition by Pacira Biosciences, Inc. Assisted in drafting and negotiation of deal documents. Post-close, consultant assisting with post-acquisition transition.

Adviser to CEO. Assisted in strategic process that resulted in $220 million acquisition by Pacira Biosciences, Inc. Ran legal department.

Initiated deal conversations with Pacira Biosciences, Inc. that led to acquisition. Led team of sixty employees focused on commercial execution and adoption of our proprietary iovera° system, a non-opioid, non-narcotic, FDA cleared medical device that treats pain in peripheral nerves throughout the body. Drove commercial initiatives to triple revenue, managed clinical efforts to support commercial expansion, and formed strategic initiatives to reduce COGS and design next generation technology.

Acting Business Officer running legal and strategic business development activities. Adviser to CEO and executive team on corporate and strategic initiatives. Responsibilities include providing counsel on business operations and external business development activities.

Strategic adviser to board, CEO and executive team on strategic initiatives, including $80 million sale of company to Auris Surgical Robotics in July of 2016. Responsibilities included providing legal counsel on corporate matters, including employment issues, business development activities, mergers and acquisitions, corporate governance, board meetings, and SEC matters.

Oversaw day-to-day operations including business development, legal, marketing, and finance. Assist on transaction execution.http://www.vaquerocap.com/team/#edward-kleinhans

Vice President and General Counsel for Intel-GE Care Innovations. Counseled on corporate matters, including employment issues, business development activities, mergers and acquisitions, corporate governance, board meetings. Managed IP portfolio, HIPAA compliance and privacy and security aspects.

Managed legal affairs and corporate development activities for drug development company. Adviser to CEO on corporate matters. Prepared, reviewed and negotiated contracts. Managed outside counsel and vendors.

Legal counsel for life science companies. . Engagements included Acting General Counsel for Intel-GE Care Innovations, Affymetrix, Inc., Intel Corporation (Digital Health Group), Beckman Coulter, Tethys Bioscience and Singulex. Counseled on corporate matters, including business development activities, corporate governance, financings, and securities transactions.

Managed legal affairs, including preparation, review and negotiation of contracts. Managed outside counsel and vendors. Prepared and distributed board materials and board sub-committee materials. Supported IP strategic discussions, including management of vast portfolio of in-licensed patents and filing of new patents.

Sold financial printing services consisting of on-line SEC filing services, printing of securities offering prospectuses and shareholder materials, IPO services, self-filing products and virtual data rooms. Clients included Blue Nile, Dynavax, Genitope, GTx, Hansen Medical, Levi, PlanetOut, Wells Fargo & Co. and Yahoo!.

Corporate associate. Practice focused on venture capital financings, IPOs, M&A and daily corporate governance. Representative transactions included:• Brightinfo $300 million M&A deal with Annuncio (represented Brightinfo).• eGreetings IPO and M&A deal with American Greetings. • AllAdvantage.com $31 million Series C financing (represented Walden Ventures).• Covalent Technologies reincorporation into Delaware and $5 million Series A financing.

Litigation associate. Drafted motions, digested depositions and edited videotapes for trial. Represented Advanced Fibre Communications and served on trial team for multi-million dollar trade secrets case.